106 related articles for article (PubMed ID: 23905404)
21. A retrospective pooled analysis of duloxetine safety in 23,983 subjects.
Gahimer J; Wernicke J; Yalcin I; Ossanna MJ; Wulster-Radcliffe M; Viktrup L
Curr Med Res Opin; 2007 Jan; 23(1):175-84. PubMed ID: 17257478
[TBL] [Abstract][Full Text] [Related]
22. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
Müller N; Schennach R; Riedel M; Möller HJ
Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
[TBL] [Abstract][Full Text] [Related]
23. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
[TBL] [Abstract][Full Text] [Related]
24. Duloxetine in the treatment of generalized anxiety disorder.
Kornstein SG; Russell JM; Spann ME; Crits-Christoph P; Ball SG
Expert Rev Neurother; 2009 Feb; 9(2):155-65. PubMed ID: 19210191
[TBL] [Abstract][Full Text] [Related]
25. Duloxetine: a dual reuptake inhibitor.
Dugan SE; Fuller MA
Ann Pharmacother; 2004 Dec; 38(12):2078-85. PubMed ID: 15522980
[TBL] [Abstract][Full Text] [Related]
26. Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial.
Frakes EP; Risser RC; Ball TD; Hochberg MC; Wohlreich MM
Curr Med Res Opin; 2011 Dec; 27(12):2361-72. PubMed ID: 22017192
[TBL] [Abstract][Full Text] [Related]
27. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
28. Duloxetine in the acute and continuation treatment of major depressive disorder.
Bochsler L; Olver JS; Norman TR
Expert Rev Neurother; 2011 Nov; 11(11):1525-39. PubMed ID: 22014130
[TBL] [Abstract][Full Text] [Related]
29. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
[TBL] [Abstract][Full Text] [Related]
30. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of duloxetine in the treatment of patients with borderline personality disorder: a pilot study.
Bellino S; Paradiso E; Bozzatello P; Bogetto F
J Psychopharmacol; 2010 Mar; 24(3):333-9. PubMed ID: 18719047
[TBL] [Abstract][Full Text] [Related]
33. Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects.
Prescrire Int; 2006 Oct; 15(85):168-72. PubMed ID: 17121211
[TBL] [Abstract][Full Text] [Related]
34. Duloxetine: a review of its use in the management of major depressive disorder in older adults.
Dhillon S
Drugs Aging; 2013 Jan; 30(1):59-79. PubMed ID: 23239363
[TBL] [Abstract][Full Text] [Related]
35. Review of duloxetine in the management of diabetic peripheral neuropathic pain.
Smith T; Nicholson RA
Vasc Health Risk Manag; 2007; 3(6):833-44. PubMed ID: 18200804
[TBL] [Abstract][Full Text] [Related]
36. Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.
Kinoshita J; Takahashi Y; Watabe AM; Utsunomiya K; Kato F
Mol Pain; 2013 Nov; 9():59. PubMed ID: 24279796
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of duloxetine for chronic pain conditions.
Mease PJ; Walker DJ; Alaka K
Pain Manag; 2011 Mar; 1(2):159-70. PubMed ID: 24646356
[TBL] [Abstract][Full Text] [Related]
38. Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy.
Wright A; Luedtke KE; Vandenberg C
J Pain Res; 2010 Dec; 4():1-10. PubMed ID: 21386950
[TBL] [Abstract][Full Text] [Related]
39. Duloxetine in diabetic neuropathy.
Smith TR
Expert Opin Pharmacother; 2006 Feb; 7(2):215-23. PubMed ID: 16433585
[TBL] [Abstract][Full Text] [Related]
40. Duloxetine use in chronic painful conditions--individual patient data responder analysis.
Moore RA; Cai N; Skljarevski V; Tölle TR
Eur J Pain; 2014 Jan; 18(1):67-75. PubMed ID: 23733529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]